Suchergebnisse - "Kirchgesner, Julien"

PubPharm (8)

1

Prevalence and Determinants of Fatigue in Patients with IBD : A Cross-Sectional Survey from the GETAID

enthalten in: Journal of Crohn's & colitis | 2023

von Amiot, A. | Chaibi, S. | Bouhnik, Y. | +111

2

Review article : Updated management of acute severe ulcerative colitis: From steroids to novel medical strategies

enthalten in: United European gastroenterology journal | 2023

von Calméjane, L. | Laharie, D. | Kirchgesner, J. | +1

3

The Impact of COVID-19 on Patients with IBD in a Prospective European Cohort Study

enthalten in: Journal of Crohn's & colitis | 2023

von Amiot, A. | Rahier, J. | Baert, F. | +110

ErratumIn: J Crohns Colitis. 2023 Jun 16;17(6):1025. - PMID 36808222

4

Impact of Anti-tumour Necrosis Factor Agents on the Risk of Colorectal Cancer in Patients with Ulcerative Colitis : Nationwide French Cohort Study

enthalten in: Journal of Crohn's & colitis | 2022

von Charkaoui, M. | Hajage, D. | Tubach, F. | +2

CommentIn: J Crohns Colitis. 2022 Jul 14;16(6):871-872. - PMID 35834841

5

Emulation of a randomized controlled trial in ulcerative colitis with US and French claims data : Infliximab with thiopurines compared to infliximab monotherapy

enthalten in: Pharmacoepidemiology and drug safety | 2022

von Kirchgesner, J. | Desai, R. | Schneeweiss, M. | +3

6

Fecal microbiota and bile acids in IBD patients undergoing screening for colorectal cancer

enthalten in: Gut microbes | 2022

von Lavelle, A. | Nancey, S. | Reimund, J. | +17

7

The IBD-disk Is a Reliable Tool to Assess the Daily-life Burden of Patients with Inflammatory Bowel Disease

enthalten in: Journal of Crohn's & colitis | 2021

von Tadbiri, S. | Nachury, M. | Bouhnik, Y. | +109

8

Maintenance of Remission Among Patients With Inflammatory Bowel Disease After Vedolizumab Discontinuation : A Multicentre Cohort Study

enthalten in: Journal of Crohn's & colitis | 2020

von Martin, A. | Nachury, M. | Peyrin-Biroulet, L. | +62

1
[1]